Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.

@article{Hackett2016TestosteroneUI,
  title={Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.},
  author={Geoffrey Hackett and Nigel Cole and Atif Saghir and Paul W. Jones and Richards C Strange and Sudarshan Ramachandran},
  journal={BJU international},
  year={2016},
  volume={118 5},
  pages={804-813}
}
OBJECTIVE To evaluate the sexual function response to 30 weeks' treatment with long-acting testosterone undecanoate (TU) or placebo in 199 men with type 2 diabetes and either severe or mild hypogonadism (HG). PATIENTS AND METHODS Men with HG were identified from seven primary care type 2 diabetes registers. A 30-week randomized placebo-controlled study of TU was carried out in 199 of these men (placebo, n = 107, TU, n = 92). The patient-reported outcome measure was the 15-item International… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Effects of testosterone treatment in older men

  • PJ Synder, S Bhasin, GR Cunningham
  • N Engl J Med
  • 2016

Similar Papers

Loading similar papers…